Evidence for the extent and oncological benefit of lymphadenectomy for esophageal cancer

被引:0
|
作者
Krauss, Dolores T.
Schmidt, Thomas
Bruns, Christiane J.
Fuchs, Hans F. [1 ,2 ]
机构
[1] Univ Cologne, Med Fak, Klin & Poliklin Allgemein Viszeral Thorax & Transp, Kerpener Str 62, D-50937 Cologne, Germany
[2] Univ Cologne, Uniklin Koln, Kerpener Str 62, D-50937 Cologne, Germany
来源
CHIRURGIE | 2025年
关键词
Esophagectomy; Early stage cancer; Lymph node metastases; Tumor staging; Surgical technique; LYMPH-NODE; ADENOCARCINOMA; SAFETY; RESECTION; EFFICACY; IMPACT;
D O I
10.1007/s00104-024-02215-6
中图分类号
R61 [外科手术学];
学科分类号
摘要
The prognosis for esophageal cancer is determined in particular by the depth of infiltration (T stage) and lymph node metastasis (N status). In patients with locally advanced tumors, surgical resection is the current standard. The extent of the lymphadenectomy depends on the localization of the tumor, analogous to the choice of surgical technique. For adequate tumor staging and achievement of pN0 status, seven lymph nodes without tumor metastases are necessary by definition but the current guidelines recommend 20 lymph nodes as a benchmark in an expert consensus. Despite the importance of the lymph node status for the prognosis of the patient and the already standardized use of targeted imaging of sentinel lymph nodes in other oncological disciplines, there is neither a validated method nor sufficient evidence for the benefit of lymph node mapping in esophageal cancer. The discussion about the prognostic advantage of lymphadenectomy is particularly interesting in T1 early stage cancer. Due to the technical advances of interventional endoscopy in recent years, organ preservation using endoscopic submucosal dissection (ESD) or endoscopic mucosal resection (EMR) has not only become possible but also safe to carry out and thus established as the standard with better functional results; however, if one or more risk factors are present, endoscopic ablation is no longer defined as curative and should be supplemented by further treatment, usually non-organ-preserving resection. The step from organ-preserving interventional treatment with a low complication rate to a surgical procedure with significant mortality and morbidity as well as functional limitations seems immense and requires optimization, especially in view of the technical developments of surgery in recent years. This can either aim to identify the risk of lymph node metastases more precisely or to minimize the morbidity/mortality and functional limitations of additive treatment procedures. Approaches to this are currently the subject of research and have already been safely applied in individual pilot projects.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Neoadjuvant Therapy and Lymphadenectomy in Esophageal Cancer: Both Are Essential to Maximize Survival Benefit
    Pandey, Durgatosh
    Pandey, Rambha
    Garg, Pankaj Kumar
    ANNALS OF SURGERY, 2017, 265 (04) : E41 - E42
  • [32] Lymph Node Status After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Implications for the Extent of Lymphadenectomy
    Robb, William B.
    Maillard, Emilie
    Mariette, Christophe
    ANNALS OF SURGERY, 2017, 266 (06) : E53 - E54
  • [33] Reply to "Neoadjuvant Therapy and Lymphadenectomy in Esophageal Cancer: Both Are Essential to Maximize Survival Benefit''
    Talsma, A. Koen
    Wijnhoven, Bas P. L.
    Steyerberg, Ewout W.
    van Lanschot, J. Jan B.
    ANNALS OF SURGERY, 2017, 265 (04) : E42 - E43
  • [34] Extent of lymphadenectomy for Barrett's cancer
    Wong, Claudia Ly
    Law, Simon
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 4
  • [35] Extent of lymphadenectomy and survival in stomach cancer
    Wong, S. L.
    Ji, H.
    Birkmeyer, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [36] Commentary for an evidence-based medicine review of lymphadenectomy extent for gastric cancer
    Yang, Sun Hu
    Zhang, You Cheng
    AMERICAN JOURNAL OF SURGERY, 2012, 203 (03): : 413 - 414
  • [37] Optimum Lymphadenectomy for Esophageal Cancer
    Rizk, Nabil P.
    Ishwaran, Hemant
    Rice, Thomas W.
    Chen, Long-Qi
    Schipper, Paul H.
    Kesler, Kenneth A.
    Law, Simon
    Lerut, Toni E. M. R.
    Reed, Carolyn E.
    Salo, Jarmo A.
    Scott, Walter J.
    Hofstetter, Wayne L.
    Watson, Thomas J.
    Allen, Mark S.
    Rusch, Valerie W.
    Blackstone, Eugene H.
    ANNALS OF SURGERY, 2010, 251 (01) : 46 - 50
  • [38] The Role of Lymphadenectomy in Esophageal Cancer
    Darling, Gail
    JOURNAL OF SURGICAL ONCOLOGY, 2009, 99 (04) : 189 - 193
  • [39] The Role of Lymphadenectomy in Esophageal Cancer
    Jamieson, Glyn G.
    Lamb, Peter J.
    Thompson, Sarah K.
    ANNALS OF SURGERY, 2009, 250 (02) : 206 - 209
  • [40] Differences in Esophageal Cancer Surgery in Terms of Surgical Approach and Extent of Lymphadenectomy: Findings of an International Survey
    A. S. van Rijswijk
    E. R. C. Hagens
    D. L. van der Peet
    M. I. van Berge Henegouwen
    S. S. Gisbertz
    Annals of Surgical Oncology, 2019, 26 : 2063 - 2072